Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001591214-13-000001
Filing Date
2013-11-08
Accepted
2013-11-08 14:20:19
Documents
1
Effectiveness Date
2013-11-08
Items
Item 04: Rule 504(b)(1) (not (i), (ii) or (iii))

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8355
  Complete submission text file 0001591214-13-000001.txt   9435
Mailing Address 675 ARAPEEN DR., SUITE 302 SALT LAKE CITY X1 84108-1228
Business Address 675 ARAPEEN DR., SUITE 302 SALT LAKE CITY X1 84108-1228 646-918-7479
Jade Therapeutics, Inc. (Filer) CIK: 0001591214 (see all company filings)

EIN.: 452051096 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-206056 | Film No.: 131204000